IPO · SYMBIOTEC

Symbiotec Pharmalab IPO listing gain & performance.

Issue price, subscription, listing day and what the share did after, from NSE data. Updated every evening.

· data for the trading session of Wed 18 Nov 2026

Issue price₹988.00₹938 to ₹988
Listing gain+0.0%at the opening price
Since the IPO+64.1%₹1,621.30 on 18 Nov
Subscribed71.3×times in total

Symbiotec Pharmalab IPO in brief

Written from NSE’s data, as of 18 Nov 2026.

Symbiotec Pharmalab came to the market at ₹988.00 a share (price band ₹938 to ₹988), with bidding open from 24 August to 27 August 2026. It listed on NSE on Tuesday, 1 September 2026, opening at ₹988.00, a gain of 0.0% on the issue price, and closed the first day +11.1% from the issue price after trading between -5.4% and +19.4%. 31% of the first day’s traded shares were taken for delivery.

The issue was subscribed 71.3× in total, institutions (QIB) 172×, HNIs (NII) 73.6×, retail investors 13.0×. Across the 91 IPOs subscribed 50× or more, the median listing gain was +26.6%.

Its listing gain beat 21% of the 227 main-board IPOs since October 2024, where the median was +7.6%. 1 month after listing it was +21.3% from the issue price and +9.1% from the first-day close, while NIFTY 50 moved -6.8% over the same days. Its highest price so far was 69% above the issue price (16 Nov 2026) and its lowest 5% below it (1 Sep 2026); it closed below the issue price on 0% of the days since listing.

Share price since listing

Daily closes, adjusted for later splits and bonuses. The dashed line is the IPO price.

IPO ₹9881 Sep 202618 Nov 2026₹1,621

Subscription

Times subscribed by investor group, NSE + BSE bids as reported by NSE.

Qualified institutions (QIB)172×
Non-institutional (NII / HNI)73.6×
NII, bids above ₹10 lakh82.9×
NII, ₹2–10 lakh55.1×
Retail investors13.0×
Employees15.4×
Total71.3×

For comparison, the median main-board IPO since Oct 2024 was subscribed 28.4× in total.

Listing day

Tuesday 1 September 2026.

Open+0.0%vs issue price
High / low+19% / -5%vs issue price
Close+11.1%vs issue price
Delivery31%₹3,200 Cr traded

Returns after listing

Against the issue price and the first-day close, with NIFTY 50 and the median IPO for comparison.

After listingFrom issue priceFrom first-day closeNIFTY 50Median IPO (from issue)
1 week8 Sep 2026+10.7%-0.3%-1.7%+8.0%
1 month1 Oct 2026+21.3%+9.1%-6.8%+9.4%

IPO details

From NSE’s issue page.

Company
Symbiotec Pharmalab
NSE symbol
SYMBIOTEC
Board
Main board
Industry
Pharmaceuticals
Bidding
24 Aug – 27 Aug 2026
Price band
₹938 to ₹988
Issue price
₹988.00
Issue size
Initial Public Offer of Fresh Issue of Aggregating Up to Rs. 1,500 million and Offer for sale up to Rs. 16,070 million (Including Eligible Employees Reservation Portion of Aggregating up to Rs. 30 million and Anchor portion of 53,25,909 Equity shares)
Bid lot
15 Equity Shares and in multiples thereof
Listing date
1 September 2026
ISIN
INE899I01028

How all IPOs did after listing →IPO calendar →

Questions

What was the listing gain of the Symbiotec Pharmalab IPO?
Symbiotec Pharmalab listed on 1 September 2026 and opened +0.0% against its issue price of ₹988.00; it closed the first day +11.1% from the issue price.
What is the Symbiotec Pharmalab share price now against the IPO price?
At the close of 18 November 2026, Symbiotec Pharmalab was at ₹1,621.30, +64.1% from the IPO price of ₹988.00.
How many times was the Symbiotec Pharmalab IPO subscribed?
Symbiotec Pharmalab’s IPO was subscribed 71.3× in total; QIB 172×; NII 73.6×; retail 13.0× (NSE + BSE bids, as reported by NSE).
When was the Symbiotec Pharmalab IPO open?
Bidding ran from 24 August to 27 August 2026 at a price band of ₹938 to ₹988; the shares listed on 1 September 2026.

From NSE’s issue list and daily price files (adjusted for later splits and bonuses), and subscription as NSE reports it (NSE + BSE bids). Past IPOs do not predict future ones. Information for learning, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.